Antibiotic drugs are important weapons in the health care arsenal. Unfortunately, they also represent something of two-edged sword. They can knock out potentially deadly bacterial infections in the body. But experts generally agree that overuse has allowed bacteria to develop resistance. Some antibiotics aren't as effective as they once might have been.
FDA issues new 'scope' superbug prevention procedures
The use of the duodenoscope, which is used to examine a part of the small intestine, has been linked to the outbreak of drug-resistant so-called "superbugs" at hospitals in Los Angeles and elsewhere in the U.S. While some of the victims have filed product liability lawsuits against one of the device's leading manufacturers, the U.S. Food and Drug Administration has issued a new list of measures intended to clean the device between uses.
FDA issues new 'scope' superbug prevention procedures
The use of the duodenoscope, which is used to examine a part of the small intestine, has been linked to the outbreak of drug-resistant so-called "superbugs" at hospitals in Los Angeles and elsewhere in the U.S. While some of the victims have filed product liability lawsuits against one of the device's leading manufacturers, the U.S. Food and Drug Administration has issued a new list of measures intended to clean the device between uses.
Studies published on SSRI antidepressants and birth defects
A pair of respected medical journals published studies within the last couple of months that linked the expectant mother's use of selective serotonin reuptake inhibitor antidepressants with certain birth defects. The findings were released while SSRI antidepressant lawsuits have been filed against the makers of some of these popular drugs. Plaintiffs alleged the birth defects connection.
Studies published on SSRI antidepressants and birth defects
A pair of respected medical journals published studies within the last couple of months that linked the expectant mother's use of selective serotonin reuptake inhibitor antidepressants with certain birth defects. The findings were released while SSRI antidepressant lawsuits have been filed against the makers of some of these popular drugs. Plaintiffs alleged the birth defects connection.
Study suggests simple way to improve chemo drug performance
Chemotherapy is a powerful tool in the fight against many different forms of cancer. The problem with it is that the chemicals that are used can be deadly. Doctors don't want to give patients too much of the stuff. If they do, the intended cure could be worse than the disease.
Study suggests simple way to improve chemo drug performance
Chemotherapy is a powerful tool in the fight against many different forms of cancer. The problem with it is that the chemicals that are used can be deadly. Doctors don't want to give patients too much of the stuff. If they do, the intended cure could be worse than the disease.
New studies released on Xarelto bleeding
Medical science and countless victims have known all about the risks of gastrointestinal bleeding associated with the anticoagulant Xarelto (rivaroxaban). The bleeding risk is at the center of Xarelto lawsuits that are being filed across the nation by bleeding victims or by their surviving next-of-kin who have sought legal counsel and who have decided not to suffer in silence. Nevertheless, a pair of studies published in 2015 focus - if you will - on eye bleeding.
New studies released on Xarelto bleeding
Medical science and countless victims have known all about the risks of gastrointestinal bleeding associated with the anticoagulant Xarelto (rivaroxaban). The bleeding risk is at the center of Xarelto lawsuits that are being filed across the nation by bleeding victims or by their surviving next-of-kin who have sought legal counsel and who have decided not to suffer in silence. Nevertheless, a pair of studies published in 2015 focus - if you will - on eye bleeding.
Improving the way drugs are tested and marketed
Sometimes there is good news and not-so-good news in a trial that tests the effectiveness and safety of a potential new drug. When the sponsor of the trial either downplays or disregards the unflattering information about an unreasonable health risk, it's the patient and the patient's family who get the worst news of all.
